A roadmap to ALS prevention: strategies and priorities
J Neurol Neurosurg Psychiatry
.
2023 May;94(5):399-402.
doi: 10.1136/jnnp-2022-330473.
Epub 2023 Jan 23.
Authors
Michael Benatar
1
,
Stephen A Goutman
2
,
Kim A Staats
3
,
Eva L Feldman
2
,
Marc Weisskopf
4
,
Evelyn Talbott
5
,
Kuldip D Dave
6
,
Neil M Thakur
6
,
Ammar Al-Chalabi
7
Affiliations
1
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA MBenatar@med.miami.edu.
2
Neurology, University of Michigan, Ann Arbor, Michigan, USA.
3
Staats Life Sciences Consulting, Los Angeles, California, USA.
4
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
5
Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
6
ALS Association, Washington, District of Columbia, USA.
7
Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
PMID:
36690429
PMCID:
PMC10176353
DOI:
10.1136/jnnp-2022-330473
No abstract available
Keywords:
ALS.
Publication types
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Amyotrophic Lateral Sclerosis* / prevention & control
Humans
Grants and funding
AL-CHALABI/APR15/844-791/MNDA_/Motor Neurone Disease Association/United Kingdom
ALCHALABI-TALBOT/APR14/926-794/MNDA_/Motor Neurone Disease Association/United Kingdom
MR/R024804/1/MRC_/Medical Research Council/United Kingdom
ALCHALABI-DOBSON/APR14/829-791/MNDA_/Motor Neurone Disease Association/United Kingdom
R01 NS105479/NS/NINDS NIH HHS/United States